NCT02309385 arm group ab39c88ace8e1b103e9d6cc4e4585957 [clinicaltrials_resource:NCT02309385/arm-group/ab39c88ace8e1b103e9d6cc4e4585957]
arm group [clinicaltrials_vocabulary:arm-group]
NCT02309385 arm group ab39c88ace8e1b103e9d6cc4e4585957 [clinicaltrials_resource:NCT02309385/arm-group/ab39c88ace8e1b103e9d6cc4e4585957]
Bio2RDF identifier
NCT02309385/arm-group/ab39c88ace8e1b103e9d6cc4e4585957
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 39c88ace8e1b103e9d6cc4e4585957
description [clinicaltrials_vocabulary:description]
15% dexamethasone sodium phosp ...... eye drops in the affected eye.
identifier
clinicaltrials_resource:NCT02309385/arm-group/ab39c88ace8e1b103e9d6cc4e4585957
title
NCT02309385 arm group ab39c88ace8e1b103e9d6cc4e4585957
@en
type
label
NCT02309385 arm group ab39c88a ...... 9c88ace8e1b103e9d6cc4e4585957]
@en